标题
TAM Receptor Inhibition–Implications for Cancer and the Immune System
作者
关键词
-
出版物
Cancers
Volume 13, Issue 6, Pages 1195
出版商
MDPI AG
发表日期
2021-03-11
DOI
10.3390/cancers13061195
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP
- (2020) Yi Zhou et al. IMMUNITY
- AXL Targeting Abrogates Autophagic Flux and Induces Immunogenic Cell Death in Drug-Resistant Cancer Cells
- (2020) Maria L. Lotsberg et al. Journal of Thoracic Oncology
- Blockade of Stromal Gas6 Alters Cancer Cell Plasticity, Activates NK Cells, and Inhibits Pancreatic Cancer Metastasis
- (2020) Lucy Ireland et al. Frontiers in Immunology
- Targeting MerTK Enhances Adaptive Immune Responses After Radiation Therapy
- (2020) Garth W. Tormoen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system
- (2020) Justus Huelse et al. PHARMACOLOGY & THERAPEUTICS
- Implications of the Receptor Tyrosine Kinase Axl in Gastric Cancer Progression
- (2020) Lirui He et al. OncoTargets and Therapy
- AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells
- (2019) Hirokazu Taniguchi et al. Nature Communications
- Hematopoietic niche drives FLT3-ITD acute myeloid leukemia resistance to quizartinib via STAT5- and hypoxia- dependent up-regulation of AXL
- (2019) Pierre-Yves Dumas et al. HAEMATOLOGICA
- Pan-TAM tyrosine kinase inhibitor BMS-777607 enhances anti-PD-1 mAb efficacy in a murine model of triple-negative breast cancer
- (2019) Canan Kasikara et al. CANCER RESEARCH
- Immuno-Oncological Efficacy of RXDX-106, a Novel Small Molecule Inhibitor of the TAM (TYRO3, AXL, MER) Family of Kinases
- (2019) Yumi Yokoyama et al. CANCER RESEARCH
- Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment
- (2019) Kayla V. Myers et al. Molecular Cancer
- Targeting of the AXL receptor tyrosine kinase by small molecule inhibitor leads to AXL cell surface accumulation by impairing the ubiquitin-dependent receptor degradation
- (2019) Markus Lauter et al. Cell Communication and Signaling
- Axl Inhibitor R428 Enhances TRAIL-Mediated Apoptosis Through Downregulation of c-FLIP and Survivin Expression in Renal Carcinoma
- (2019) Seon Min Woo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MERTK Acts as a Costimulatory Receptor on Human CD8+ T Cells
- (2019) Marlies J.W. Peeters et al. Cancer Immunology Research
- Type I Interferon Receptor on NK Cells Negatively Regulates Interferon-γ Production
- (2019) Amanda J. Lee et al. Frontiers in Immunology
- Triple Therapy with MerTK and PD1 Inhibition plus Radiotherapy Promotes Abscopal Antitumor Immune Responses
- (2019) Mauricio S. Caetano et al. CLINICAL CANCER RESEARCH
- TAM receptors attenuate murine NK‐cell responses via E3 ubiquitin ligase Cbl‐b
- (2019) Leilani M. Chirino et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- AXL Targeting Overcomes Human Lung Cancer Cell Resistance to NK- and CTL-Mediated Cytotoxicity
- (2019) Stéphane Terry et al. Cancer Immunology Research
- TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti–PD-1 Therapy in Melanoma
- (2019) Alisha Holtzhausen et al. Cancer Immunology Research
- TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting
- (2019) Marlies J. W. Peeters et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The prognostic role of Gas6/Axl axis in solid malignancies: a meta-analysis and literature review
- (2018) Sheng Zhang et al. OncoTargets and Therapy
- Axl Involved in Mineral Trioxide Aggregate Induces Macrophage Polarization
- (2018) Hsiao-Wen Yeh et al. JOURNAL OF ENDODONTICS
- AXL Mediates Esophageal Adenocarcinoma Cell Invasion through Regulation of Extracellular Acidification and Lysosome Trafficking
- (2018) Selma Maacha et al. NEOPLASIA
- Inhibition of MERTK promotes suppression of tumor growth in BRAF mutant and BRAF wild-type melanoma
- (2018) Lenka Sinik et al. MOLECULAR CANCER THERAPEUTICS
- Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer
- (2018) Jeanne M. Quinn et al. MOLECULAR CANCER THERAPEUTICS
- Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression
- (2017) Canan Kasikara et al. MOLECULAR CANCER RESEARCH
- Axl inhibition induces the antitumor immune response which can be further potentiated by PD-1 blockade in the mouse cancer models
- (2017) Zhiqiang Guo et al. Oncotarget
- PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?
- (2017) Sylvain Simon et al. OncoImmunology
- UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models
- (2016) Deborah DeRyckere et al. CLINICAL CANCER RESEARCH
- The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer
- (2016) J. Antony et al. Science Signaling
- The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer
- (2016) J. Antony et al. Science Signaling
- TAM Receptor Signaling in Immune Homeostasis
- (2015) Carla V. Rothlin et al. Annual Review of Immunology
- MERTK as negative regulator of human T cell activation
- (2015) Raquel Cabezo´n et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Viral apoptotic mimicry
- (2015) Ali Amara et al. NATURE REVIEWS MICROBIOLOGY
- Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemia
- (2015) Alisa B. Lee-Sherick et al. Oncotarget
- Axl as a mediator of cellular growth and survival
- (2015) Haley Axelrod et al. Oncotarget
- The Mertk receptor tyrosine kinase promotes T–B interaction stimulated by IgD B-cell receptor cross-linking
- (2014) Wen-Hai Shao et al. JOURNAL OF AUTOIMMUNITY
- Overexpression of MERTK Receptor Tyrosine Kinase in Epithelial Cancer Cells Drives Efferocytosis in a Gain-of-Function Capacity
- (2014) Khanh-Quynh N. Nguyen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells
- (2014) Magdalena Paolino et al. NATURE
- Diversification of TAM receptor tyrosine kinase function
- (2014) Anna Zagórska et al. NATURE IMMUNOLOGY
- Differential TAM receptor–ligand–phospholipid interactions delimit differential TAM bioactivities
- (2014) Erin D Lew et al. eLife
- Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma
- (2013) I. Ben-Batalla et al. BLOOD
- T Cell-Derived Protein S Engages TAM Receptor Signaling in Dendritic Cells to Control the Magnitude of the Immune Response
- (2013) Eugenio A. Carrera Silva et al. IMMUNITY
- MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis
- (2013) Rebecca S. Cook et al. JOURNAL OF CLINICAL INVESTIGATION
- Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia
- (2013) A B Lee-Sherick et al. ONCOGENE
- AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells
- (2013) M K Asiedu et al. ONCOGENE
- The receptor tyrosine kinase Axl regulates cell–cell adhesion and stemness in cutaneous squamous cell carcinoma
- (2013) M A Cichoń et al. ONCOGENE
- Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer
- (2013) L. Bosurgi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer
- (2012) R M A Linger et al. ONCOGENE
- Phosphoproteomic Screen Identifies Potential Therapeutic Targets in Melanoma
- (2011) K. Tworkoski et al. MOLECULAR CANCER RESEARCH
- A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells
- (2011) Kim J. Png et al. NATURE
- Mer receptor tyrosine kinase inhibition impedes glioblastoma multiforme migration and alters cellular morphology
- (2011) A E J Rogers et al. ONCOGENE
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Constitutive exposure of phosphatidylserine on viable cells
- (2011) K. Segawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer
- (2010) S. J. Holland et al. CANCER RESEARCH
- Inhibition of Mer and Axl Receptor Tyrosine Kinases in Astrocytoma Cells Leads to Increased Apoptosis and Improved Chemosensitivity
- (2010) A. K. Keating et al. MOLECULAR CANCER THERAPEUTICS
- An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies
- (2010) X Ye et al. ONCOGENE
- Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer
- (2010) K Vuoriluoto et al. ONCOGENE
- Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
- (2009) C. Gjerdrum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Axl/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell development
- (2008) I.-K. Park et al. BLOOD
- Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-κB and Brg-1
- (2008) K-Y Tai et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now